Recursion Pharmaceuticals filed documents with the SEC regarding CEO stock sales, while Morgan Stanley cut the price target for the company.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Morgan Stanley published a report predicting that the Democrats will regain control.09:43
  • BNP Paribas and Morgan Stanley have been appointed to handle a share sale for Jio.08:37
• Recursion (United States) →

  company in Salt Lake City, United States

  Nothing else this week.

• Securities and Exchange Commission →

  government agency of the Philippines

  • BlackRock manages the iShares MSCI India ETF, and filings are being made to the Securities and Exchange Commission.Wed 23:32
  • MicroVision, Inc. successfully completed key steps in its listing process on Nasdaq, including SEC declaration and prospectus availability.Wed 22:37

Related events

• Morgan Stanley and Carlyle Group released research reports and price targets for a company whose stock trades on the Nasdaq platform.Jun 7
• Morgan Stanley was involved in market activity on the electronic stock exchange, with filings received regarding this activity.Sep 9
• Colgate-Palmolive Company disclosed financial filings to the SEC, and CEO Noel Wallace sold company stock.Oct 18
• VSE Corporation was listed on the Nasdaq stock exchange and received analyst coverage and price targets from Morgan Stanley and TipRanks.Jun 30
• Morgan Stanley and Jefferies Financial Group raised price targets and upgraded shares for DT Midstream, Inc., following institutional filings with the SEC.Jul 28